Viewing nowDongkwang Eperisone Tablet (Eperisone Hydrochloride)
Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 201310292 · Approved 2013.11.26 · Insurance code 645905540
Treatment of musculoskeletal pain-related muscle spasms and neurological spastic paralysis.
This medication is effective for painful muscle spasms associated with musculoskeletal disorders, such as shoulder-hand syndrome, shoulder periarthritis, and low back pain. It is also used to relieve spastic symptoms due to various neurological conditions, including spastic paralysis caused by neurological diseases, cerebrovascular disorders, sequelae of spinal cord injury, and cerebral palsy. This medication helps reduce muscle stiffness and alleviate pain, improving patients' daily movements and quality of life. Therefore, it is used to improve muscle stiffness and pain associated with musculoskeletal and neurological disorders.
As eperisone hydrochloride, take 50mg orally three times a day after meals. Dosage may be adjusted appropriately according to age and symptoms.
This medication should not be used in certain patients. First, individuals who have had allergic reactions to this medication should avoid taking it. Also, patients with severe muscle weakness symptoms should not take this medication. This medication contains lactose, making it unsuitable for patients with genetic disorders that prevent lactose digestion. Patients allergic to soybean oil or peanuts should also avoid using this medication. There are patients who should use this medication with caution. Patients with a history of drug allergies should be careful. Patients with liver function issues or liver disease should be cautious as this medication may exacerbate liver function. Patients with metabolic abnormalities related to fats, hyperlipidemia, diabetic dyslipidemia, or pancreatitis should also use this medication carefully. Since this medication may cause various side effects, careful observation is needed. Shock reactions may rarely occur, so if symptoms appear, use should be stopped immediately and managed. Liver enzyme levels may increase, so regular liver function tests are recommended. Renal dysfunction or hematological abnormalities, such as anemia, may also occur rarely. Hypersensitivity reactions, such as skin rashes or itching, may appear. Neurological symptoms may include insomnia, drowsiness, headaches, and limb paralysis. Gastrointestinal symptoms may include nausea, vomiting, loss of appetite, and abdominal pain. Urinary issues, such as urinary retention or incontinence, may also arise. Systemically, symptoms may include weakness, dizziness, and reduced muscle tension. Serious skin reactions such as toxic epidermal necrolysis syndrome may occur, so if fever, rash, blisters, itching, or conjunctival injection occurs, medication should be stopped immediately. During treatment with this medication, symptoms such as weakness, staggering, and drowsiness may appear. If these symptoms occur, the dosage should be reduced or usage should be stopped. Drowsiness or decreased attention may occur, so it is safer to avoid driving or operating machinery. Patients at risk for fat overload should monitor blood lipid levels and adjust the dosage of the medication if necessary. Interactions may occur when used with other medications, especially with similar drugs or muscle relaxants, so caution is advised. Pregnant women or women of childbearing potential should use this medication only if the therapeutic benefits outweigh the risks since its safety has not been established. Nursing mothers should avoid taking this medication if possible, and if it must be taken, it is recommended to stop breastfeeding. Safety has not been sufficiently established for children, so they should be approached with caution. Older adults may be affected more significantly by the medication due to decreased body functions, so they should use it carefully with dosage adjustments.
Shock (severe allergic reaction), anaphylaxis (severe allergic reaction), angioedema (severe swelling), toxic epidermal necrolysis, and mucocutaneous-eye syndrome (Stevens-Johnson syndrome, severe skin abnormal reactions), liver dysfunction (increased ALT, AST, ALP, liver abnormalities), renal abnormalities (proteinuria, increased BUN), anemia, angioedema, severe rashes with fever, blisters, oral mucosal pain.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air from entering, and it is best to keep it at room temperature, between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy.
White round film-coated tablet
30 tablets/bottle, 1000 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEperisone Hydrochloride 50mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Prescription medication
Aju Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.